End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
146.4 USD | -.--% |
|
-0.46% | -4.75% |
28/06 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
28/06 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
35TCr | - | - | - | - | ||
82TCr | ||||||
64TCr | ||||||
31TCr | ||||||
30TCr | ||||||
24TCr |